Humana Inc. $HUM Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System trimmed its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 24.4% in the first quarter, HoldingsChannel reports. The firm owned 171,183 shares of the insurance provider’s stock after selling 55,174 shares during the period. California Public Employees Retirement System’s holdings in Humana were worth $29,681,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Revolve Wealth Partners LLC purchased a new stake in Humana in the 4th quarter valued at approximately $202,000. Woodline Partners LP increased its position in Humana by 460.0% during the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after buying an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC increased its position in Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after buying an additional 452 shares in the last quarter. Cresset Asset Management LLC raised its holdings in shares of Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after acquiring an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd raised its holdings in shares of Humana by 58.5% in the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after acquiring an additional 879 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Performance

Humana stock opened at $404.80 on Wednesday. The stock has a fifty day moving average price of $358.69 and a 200 day moving average price of $262.23. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The firm has a market capitalization of $48.60 billion, a P/E ratio of 43.29, a PEG ratio of 2.17 and a beta of 0.71. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUMGet Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter in the previous year, the business earned $11.58 EPS. The firm’s revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Equities research analysts anticipate that Humana Inc. will post 9.46 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts recently commented on HUM shares. Truist Financial increased their price objective on Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Zacks Research upgraded shares of Humana from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Seaport Research Partners cut shares of Humana to a “neutral” rating in a research note on Wednesday, May 20th. Bank of America reiterated a “neutral” rating and set a $410.00 price target on shares of Humana in a report on Monday. Finally, Leerink Partners boosted their price objective on shares of Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research report on Thursday, April 30th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $327.17.

Check Out Our Latest Stock Report on Humana

About Humana

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Read More

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.